Intrinsic Innate Immune Responses Control Viral Growth and Protect against Neuronal Death in an Ex Vivo Model of West Nile Virus-Induced Central Nervous System Disease
Authors:
- 25 August 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 95 (18) , e0083521
Abstract
West Nile virus is the most common cause of epidemic encephalitis in the United States and can result in debilitating CNS disease. There are no effective vaccines or treatments for WNV-induced CNS disease in humans.Keywords
Funding Information
- U.S. Department of Veterans Affairs (BX000963)
This publication has 62 references indexed in Scilit:
- Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's diseaseHuman Molecular Genetics, 2011
- The Role of Nuclear Factor κB in the Interferon ResponseJournal of Interferon & Cytokine Research, 2011
- The Immune Adaptor Molecule SARM Modulates Tumor Necrosis Factor Alpha Production and Microglia Activation in the Brainstem and Restricts West Nile Virus PathogenesisJournal of Virology, 2009
- Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous SystemJournal of Virology, 2008
- Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitisJournal of Experimental Medicine, 2008
- West Nile Virus-Induced Neuroinflammation: Glial Infection and Capsid Protein-Mediated NeurovirulenceJournal of Virology, 2007
- CD40-CD40 Ligand Interactions Promote Trafficking of CD8 + T Cells into the Brain and Protection against West Nile Virus EncephalitisJournal of Virology, 2007
- Caspase 3-Dependent Cell Death of Neurons Contributes to the Pathogenesis of West Nile Virus EncephalitisJournal of Virology, 2007
- CD4+T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous SystemJournal of Virology, 2006
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005